Inicio・Lista de Acciones・Compugen Ltd

Compugen Ltd

Cerrado

2.12 0.47

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

2.1

Máximo

2.12

Métricas clave
By Trading Economics
Ingresos	663K -7M
Ventas	426K 2.6M
P/B Media del Sector	6.079 47.946
BPA	-0.07
Margen de beneficios	-269.254
Empleados	75
EBITDA	665K -7M

Recomendaciones
By TipRanks
Recomendaciones	Compra Fuerte
Estimación a 12 Meses	+111.27% upside

Dividendos
By Acuity
Próximas Ganancias	9 nov 2026

Estadísticas de Mercado
By TradingEconomics
Capitalización Mercado	-6.3M 219M
Apertura anterior	1.65
Cierre anterior	2.12

Compugen Ltd Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

11 oct 2026, 23:51 UTC

China's Inflation Rate YoY for September 2026 set to release on October 14, with expectations of a slight increase to 0.1%, amid cautious market sentiment influenced by global economic factors and U.S. Treasury yields.

11 oct 2026, 23:51 UTC

China's PPI data release on October 14, 2026, expected to show a year-on-year increase of 4.5%, amid cautious optimism and potential implications for global inflation and monetary policy.

11 oct 2026, 23:51 UTC

China's inflation rate expected to rise by 0.3% MoM amid cautious market sentiment and global economic pressures ahead of key CPI reports.

11 oct 2026, 23:41 UTC

U.S. Import Prices Report on October 16 Forecasts 0.7% Increase Amid Cautious Market Sentiment and Geopolitical Tensions

11 oct 2026, 23:41 UTC

U.S. Export Prices Expected to Rise 0.01% in September Amid Mixed Economic Sentiment and Cautious Market Optimism

11 oct 2026, 23:31 UTC

Canada's Housing Starts Data Release on October 16 Forecasts Decline to 237.5K Units Amid Cautious Market Sentiment

11 oct 2026, 23:21 UTC

Core Producer Price Index (PPI) for September 2026 set to release on October 15, with a forecasted increase of 0.3%, amid mixed economic sentiment and rising Treasury yields impacting investor optimism.

11 oct 2026, 23:21 UTC

Market Braces for September PPI Release Amid Rising Treasury Yields and Fed Rate Hike Speculation

11 oct 2026, 23:21 UTC

Market Awaits Philadelphia Fed Manufacturing Index Release Amid Mixed Economic Sentiment and Caution Over Inflationary Pressures.

11 oct 2026, 23:21 UTC

Investors Brace for NY Empire State Manufacturing Index Release Amid High Treasury Yields and Inflation Concerns on October 15, 2026.

11 oct 2026, 23:11 UTC

Australia's Full-Time Employment Change Data Set for Release on October 15, Anticipated to Reflect Economic Resilience Amid Global Challenges.

11 oct 2026, 23:11 UTC

Australia's September 2026 unemployment rate forecasted to rise to 4.6%, raising market concerns ahead of the October release amid global economic volatility.

11 oct 2026, 23:11 UTC

Australia's Employment Change Report on October 15 Expected to Show Job Growth Amid Positive Labor Market Sentiment, but Analysts Warn of Potential Volatility.

11 oct 2026, 23:01 UTC

Investors Brace for Volatility Ahead of October 14 CPI Release Amid Rising Inflation Concerns and Fed Rate Hike Speculations.

11 oct 2026, 23:01 UTC

Core Inflation Rate for September 2026 set to rise by 0.2%, influencing market sentiment and Federal Reserve rate hike expectations ahead of key CPI reports.

11 oct 2026, 23:01 UTC

U.S. CPI Expected to Rise to 336.67 Amid Inflation Concerns and Market Volatility Ahead of October Release

11 oct 2026, 23:01 UTC

Core Inflation Rate YoY for September 2026 set to rise slightly to 2.5%, as markets brace for potential Federal Reserve interest rate hikes amid geopolitical tensions and high Treasury yields.

11 oct 2026, 23:01 UTC

Investors Brace for U.S. CPI Release on October 14, Anticipating Inflation Rise to 3.7% and Potential Fed Policy Shifts

11 oct 2026, 23:01 UTC

U.S. Inflation Rate Expected to Rise 0.6% in September Amidst Market Caution and High Treasury Yields Ahead of Federal Reserve Decisions

11 oct 2026, 23:01 UTC

Macro News

Gold prices are declining amid escalating geopolitical tensions and rising U.S. Treasury yields, remaining below its 20-day moving average.

11 oct 2026, 23:01 UTC

The EUR/NOK is advancing in early trading, influenced by geopolitical tensions and rising yields.

11 oct 2026, 23:01 UTC

The EUR/SEK is trading higher in early trading, rebounding after a slight dip amid rising yields and geopolitical tensions affecting market sentiment.

11 oct 2026, 22:51 UTC

Brazil's Retail Sales MoM data for August 2026, expected to rise by 0.8%, set for release on October 15 amid cautious economic sentiment influenced by global trends.

11 oct 2026, 22:31 UTC

Japan's Machinery Orders MoM data set for October 14, with a modest growth forecast of 0.03% amid cautious market sentiment following recent volatility.

11 oct 2026, 22:31 UTC

RBA Meeting Minutes on October 13 Expected to Address Inflation Concerns and Future Monetary Policy Adjustments.

11 oct 2026, 22:31 UTC

Australia's NAB Business Confidence Report Set for Release Amidst Cautious Market Sentiment and Ongoing Economic Challenges

11 oct 2026, 22:21 UTC

Singapore's Q3 2026 GDP Growth Rate Expected at 0.9%, Amid Cautious Optimism and Input Cost Concerns

11 oct 2026, 22:21 UTC

Mortgage Rates Hit 7.49% Amid Rising Treasury Yields and Inflation Concerns, Sparking Caution in Housing Market Ahead of Upcoming Data Release

11 oct 2026, 22:11 UTC

Brazil's Central Bank to Provide Key Interest Rate Insights Amid Political Turmoil on October 13, 2026.

11 oct 2026, 22:01 UTC

South Korea's September 2026 unemployment rate release on October 15 expected to reveal job market stability amid global inflation concerns.

Comparación entre iguales

Cambio de precio

Compugen Ltd previsión

Precio Objetivo

By TipRanks

111.27% repunte

Estimación a 12 Meses

Media 4.5 USD 111.27%

Máximo 6 USD

Mínimo 4 USD

De acuerdo con 4 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Compugen Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

4 ratings

Comprar

Mantener

Vender

De acuerdo con 4 analistas que ofrecen calificaciones bursátiles a para Compugen Ltd Dist en los últimos 3 meses.

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

Acerca de Compugen Ltd

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tumors; COM902, a therapeutic antibody targeting TIGIT, which is in Phase I monotherapy clinical study in patients with advanced malignancies through sequential dose escalations; Bapotulimab, a therapeutic antibody targeting ILDR2 that is in Phase I clinical study in patients with naïve head and neck squamous cell carcinoma; and Rilvegostomig, a novel anti-TIGIT/PD-1 bispecific antibody, which is in Phase II clinical study in patients with advanced or metastatic non-small cell lung cancer. Its therapeutic pipeline also includes early-stage immuno-oncology programs focused to address various mechanisms of immune resistance; and COM503, high affinity antibody, which blocks the interaction between IL-18 binding protein and IL-18. The company has collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics against the company's immune checkpoint regulators; Bristol-Myers Squibb to evaluate the safety and tolerability of COM701 in combination with Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor Opdivo in patients with advanced solid tumors; and Johns Hopkins School of Medicine to evaluate novel T cell and myeloid checkpoint targets. It has license agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products; and research collaboration with Johns Hopkins University for myeloid. Compugen Ltd. was incorporated in 1993 and is headquartered in Holon, Israel.